Evidence map›Paper›PMID 27882129›Full record

ArticleExperimental and therapeutic medicine2016

Whole-genome resequencing of 100 healthy individuals using DNA pooling.

Xiaobin Wang, Weiguo Sui, Weiqing Wu, Xianliang Hou, Minglin Ou, Yueying Xiang, Yong Dai

Abstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiaobin WangHealth Management Centre, The Affiliated Guilin Hospital, Southern Medical University, Guilin, Guangxi 541000, P.R. China; Guangxi Key Laboratory of Metabolic Diseases Research, Guilin, Guangxi 541000, P.R. China.
Weiguo SuiGuangxi Key Laboratory of Metabolic Diseases Research, Guilin, Guangxi 541000, P.R. China; Department of Nephrology, Guilin 181st Hospital, Guilin, Guangxi 541000, P.R. China.
Weiqing WuHealth Management Centre, The Second Clinical Medical College, Jinan University, Shenzhen, Guangdong 518001, P.R. China.
Xianliang HouGuangxi Key Laboratory of Metabolic Diseases Research, Guilin, Guangxi 541000, P.R. China; Department of Nephrology, Guilin 181st Hospital, Guilin, Guangxi 541000, P.R. China; College of Life Science, Guangxi Normal University, Guilin, Guangxi 541001, P.R. China.
Minglin OuGuangxi Key Laboratory of Metabolic Diseases Research, Guilin, Guangxi 541000, P.R. China; Department of Nephrology, Guilin 181st Hospital, Guilin, Guangxi 541000, P.R. China.
Yueying XiangHealth Management Centre, The Affiliated Guilin Hospital, Southern Medical University, Guilin, Guangxi 541000, P.R. China.
Yong DaiGuangxi Key Laboratory of Metabolic Diseases Research, Guilin, Guangxi 541000, P.R. China; Department of Nephrology, Guilin 181st Hospital, Guilin, Guangxi 541000, P.R. China; Clinical Medical Research Center, The Second Clinical Medical College, Jinan University, Shenzhen, Guangdong 518001, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the advent of next-generation sequencing technology, the cost of sequencing has significantly decreased. However, sequencing costs remain high for large-scale studies. In the present study, DNA pooling was applied as a cost-effective strategy for sequencing. The sequencing results for 100 healthy individuals obtained via whole-genome resequencing and using DNA pooling are presented in the present study. In order to minimise the likelihood of systematic bias in sampling, paired-end libraries with an insert size of 500 bp were prepared for all samples and then subjected to whole-genome sequencing using four lanes for each library and resulting in at least a 30-fold haploid coverage for each sample. The NCBI human genome build37 (hg19) was used as a reference genome for the present study and the short reads were aligned to the reference genome achieving 99.84% coverage. In addition, the average sequencing depth was 32.76. In total, ~3 million single-nucleotide polymorphisms were identified, of which 99.88% were in the NCBI dbSNP database. Furthermore, ~600,000 small insertion/deletions, 500,000 structure variants, 5,000 copy number variations and 13,000 single nucleotide variants were identified. According to the present study, the whole genome has been sequenced for a small sample subjects from southern China for the first time. Furthermore, new variation sites were identified by comparing with the reference sequence, and new knowledge of the human genome variation was added to the human genomic databases. Furthermore, the particular distribution regions of variation were illustrated by analyzing various sites of variation, such as single-nucleotide polymorphisms.

Indexed as

DNA poolinggenetic variationsingle nucleotide polymorphismvariation sitewhole-genome resequencing

Identifiers

PMID27882129
PMCPMC5103757

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.